C20ORF7 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.043400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.618800E-01
Normal-vs-Stage2
6.522600E-01
Normal-vs-Stage3
4.945000E-01
Normal-vs-Stage4
7.195600E-02
Stage1-vs-Stage2
8.786400E-01
Stage1-vs-Stage3
5.058800E-01
Stage1-vs-Stage4
9.757700E-02
Stage2-vs-Stage3
4.325000E-01
Stage2-vs-Stage4
1.694450E-01
Stage3-vs-Stage4
7.246600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.113400E-01
Normal-vs-AfricanAmerican
6.409000E-01
Normal-vs-Asian
8.714000E-01
Caucasian-vs-AfricanAmerican
9.556000E-01
Caucasian-vs-Asian
3.493600E-01
AfricanAmerican-vs-Asian
4.138200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.834800E-01
Normal-vs-Female
6.068000E-01
Male-vs-Female
4.915600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.134500E-02
Normal-vs-Age(41-60Yrs)
8.003600E-01
Normal-vs-Age(61-80Yrs)
6.700800E-01
Normal-vs-Age(81-100Yrs)
9.512200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.755790E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.613400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.152300E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.127000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.085200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.685400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.482600E-01
Normal-vs-Daily Drinker
7.453000E-01
Normal-vs-Weekly Drinker
9.619600E-01
Normal-vs-Occasional Drinker
6.047600E-01
Normal-vs-Social Drinker
9.534200E-01
Non Drinker-vs-Daily Drinker
7.254000E-01
Non Drinker-vs-Weekly Drinker
2.659200E-01
Non Drinker-vs-Occasional Drinker
4.733200E-01
Non Drinker-vs-Social Drinker
2.533400E-01
Daily Drinker-vs-Weekly Drinker
5.130400E-01
Daily Drinker-vs-Occasional Drinker
8.557000E-01
Daily Drinker-vs-Social Drinker
4.962200E-01
Weekly Drinker-vs-Occasional Drinker
5.313000E-01
Weekly Drinker-vs-Social Drinker
9.837200E-01
Occasional Drinker-vs-Social Drinker
5.149800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.749600E-01
Normal-vs-Grade 2
8.413400E-01
Normal-vs-Grade 3
8.289000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.780000E-01
Grade 1-vs-Grade 3
4.666200E-01
Grade 1-vs-Grade 4
8.749600E-01
Grade 2-vs-Grade 3
6.825400E-01
Grade 2-vs-Grade 4
8.413400E-01
Grade 3-vs-Grade 4
8.289000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.174000E-01
Normal-vs-NonDiabetic
8.200600E-01
Diabetic-vs-NonDiabetic
3.150200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.741400E-01
Normal-vs-NoPancreatitis
6.940000E-01
Pancreatitis-vs-NoPancreatitis
9.744800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.727200E-01
Normal-vs-N1
6.060600E-01
N0-vs-N1
9.141500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.441800E-01
Normal-vs-TP53-NonMutant
7.348000E-01
TP53-Mutant-vs-TP53-NonMutant
5.768200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
